Guided Therapeutics (GTHP) Interest Expenses (2010 - 2026)
Guided Therapeutics (GTHP) posted Interest Expenses of $577000.0 for Q4 2025, up 347.29% sequentially from $129000.0 in Q3 2025, and up 330.6% YoY from $134000.0 in Q4 2024.
Guided Therapeutics (GTHP) Interest Expenses (2010 - 2026) Analysis & Trends
Guided Therapeutics has reported Interest Expenses for 16 years, with the latest figure at $577000.0 in Q4 2025.
- Quarterly Interest Expenses rose 330.6% year-over-year to $577000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.0 million (up 480.46% YoY) and the FY2025 annual result came in at $17.4 million, down 0.93% from the prior year.
- Interest Expenses improved to $577000.0 in Q4 2025 per GTHP's latest filing, from $129000.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $594000.0 in Q3 2021 and troughed at -$493000.0 in Q4 2021.
- A 5-year average of $142150.0 and a median of $140500.0 in 2024 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2021 and 2025: Interest Expenses tumbled 127.19% in 2021, then jumped 330.6% in 2025.
- Over 5 years, Interest Expenses stood at -$493000.0 in 2021, then gained by 26.37% to -$363000.0 in 2022, then soared by 72.73% to -$99000.0 in 2023, then surged by 235.35% to $134000.0 in 2024, then surged by 330.6% to $577000.0 in 2025.
- According to Business Quant data, Interest Expenses over the past three periods registered $577000.0, $129000.0, and $157000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 351.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 141.00 Mn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 176.00 Mn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 96.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 114.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | -110.42 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 15.80 Mn |
| 10 | Guided Therapeutics | 21.24 Mn | 21.23 Mn | - | 136,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 899,000.00 |
| Jun 30, 2026 | 899,000.00 |
| Dec 31, 2025 | 577,000.00 |
| Dec 31, 2025 | 577,000.00 |
| Sep 30, 2025 | 129,000.00 |
| Sep 30, 2025 | 129,000.00 |
| Jun 30, 2025 | 157,000.00 |
| Jun 30, 2025 | 157,000.00 |
| Mar 31, 2025 | 147,000.00 |
| Mar 31, 2025 | 147,000.00 |
| Dec 31, 2024 | 134,000.00 |
| Dec 31, 2024 | 134,000.00 |
| Sep 30, 2024 | 197,000.00 |
| Sep 30, 2024 | 197,000.00 |
| Jun 30, 2024 | 75,000.00 |
| Jun 30, 2024 | 75,000.00 |
| Mar 31, 2024 | 64,000.00 |
| Mar 31, 2024 | 64,000.00 |
| Dec 31, 2023 | -99,000.00 |
| Dec 31, 2023 | -99,000.00 |